The Short Bowel Syndrome Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Short Bowel Syndrome Market?
The market size of the Short Bowel Syndrome has seen a swift increase in recent years. The market is expected to expand from $2.69 billion in 2024 to $3.09 billion in 2025, showing a compound annual growth rate (CAGR) of 14.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Short Bowel Syndrome Industry?
The Short Bowel Syndrome Global Market is forecasted to reach $5.33 billion by 2029, with a compound annual growth rate (CAGR) of 14.6%.
Download Your Free Sample of the 2025 Short Bowel Syndrome Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Short Bowel Syndrome Market?
The key drivers in the Short Bowel Syndrome market are:
• Rising prevalence of short bowel syndrome
• Growing adoption of parenteral and enteral nutrition therapy
• Expanding clinical research and drug development
• Increasing awareness and early diagnosis of SBS
Global Market Segmentation: Identifying Major Short Bowel Syndrome Industry Segments
The short bowel syndrome market covered in this report is segmented –
1) By Type: Glucagon-Like Peptide (GLP-2), Growth Hormone, Glutamine
2) By Diagnosis: Physical Exam, Blood Tests, Fecal Fat Tests, Imaging Procedures, Other Diagnosis
3) By Treatment: Nutritional Therapy, Medications, Surgery, Transplant
4) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Other Distribution Channels
Pre-order the 2025 Short Bowel Syndrome Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Short Bowel Syndrome Market?
The key trends in the Short Bowel Syndrome market are:
• The prospect of developing intestinal rehabilitation therapies is a prominent upcoming trend.
• The progression towards small intestine transplantation techniques shapes the future of this market.
• The management of Short Bowel Syndrome via telemedicine is considered as a novel trend.
• The integration of artificial intelligence in treatment planning for Short Bowel Syndrome appears to be an upcoming trend.
Who Are the Top Competitors & Leading Players in the Short Bowel Syndrome Market?
Major companies in the Short Bowel Syndrome market are:
• Nestlé SA
• Pfizer Inc
• Johnson & Johnson
• Sanofi SA
• Nutrinia
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Zealand Pharma
• Baxter International Inc.
• Alnylam Pharmaceuticals
• OPKO Health Inc
• Ironwood Pharmaceuticals Inc.
• Hanmi Pharm Co. Ltd
• Ardelyx Inc
• Emmaus Life Sciences Inc
• Jaguar Health
• 9 Meters Biopharma Inc.
• OxThera Inc.
• Adocia SAS
• EnteraBio Ltd
• GLyPharma Therapeutic Inc.
Regional Dominance: Which Area Leads the Global Short Bowel Syndrome Market?
North America was the largest region in the short bowel syndrome market in 2024
